Price
$11.89-16%1Y
1M-1.8%1Y-16%
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Above averageValue45
Quality80
Momentum20
Growth88
What they do
Established in 1984, we are an integrated global pharmaceutical company committed to accelerating access to affordable and innovative medicines. Our reportable operating segments are as follows:
In the company’s own words · 20-F filed May 29, 2026 · SEC EDGAR
P/E (TTM)-
Market Cap$12.70B
1Y Return-16%
5Y Return-2.3%
For the full year FY2025, revenue was INR 325.5B (+17% year on year) and net income INR 56.5B.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.
Drug Manufacturers - Specialty & Generic
Ranks #6 of 29 by Smart Score